Related Experiment Video
Updated: Apr 23, 2026
Models of Bone Metastasis
Published on: September 4, 2012
Investigating the efficacy of bisphosphonates treatment against multiple myeloma induced bone disease using a
Bing Ji1, Qing Yang2, Paul G Genever3
1School of Control Science and Engineering, Shandong University, 17923 Jingshi Road, Jinan, 250061, People's Republic of China.
Abstract:
Multiple myeloma (MM)-induced bone disease is mortal for most MM patients. Bisphosphonates are first-line treatment for MM-induced bone disease, since it can inhibit osteoclast activity and the resultant bone resorption by suppressing the differentiation of osteoclast precursors into mature osteoclasts, promoting osteoclast apoptosis and disrupting osteoclast function. However, it is still unclear whether bisphosphonates have an anti-tumour effect. In our previous work, a computational model was built to simulate the pathology of MM-induced bone disease. This paper extends this proposed computational model to investigate the efficacy of bisphosphonates treatment and then clear the controversy of this therapy. The extended model is validated through the good agreement between simulation results and experimental data. The simulation results suggest that bisphosphonates indeed have an anti-tumour effect.
Insights
Bisphosphonates, a common treatment for multiple myeloma bone disease, may also possess anti-tumour properties. Computational modeling suggests this therapy effectively combats cancer progression in multiple myeloma patients.
Area of Science:
- Oncology
- Pharmacology
- Computational Biology
Background:
- Multiple myeloma (MM)-induced bone disease significantly impacts patient mortality.
- Bisphosphonates are the standard treatment, primarily targeting osteoclast activity to prevent bone resorption.
- The anti-tumour efficacy of bisphosphonates in MM remains controversial and requires clarification.
Purpose of the Study:
- To extend a previously developed computational model to investigate bisphosphonate efficacy in MM.
- To address the ongoing debate regarding the anti-tumour effects of bisphosphonates.
- To simulate and analyze the impact of bisphosphonate treatment on MM pathology.
Main Methods:
- Development and validation of an extended computational model simulating MM bone disease.
- Utilizing the model to simulate the effects of bisphosphonate treatment.
- Comparing simulation outcomes with existing experimental data for model validation.
Main Results:
- The extended computational model demonstrated good agreement with experimental data.
- Simulation results indicate that bisphosphonates exhibit a significant anti-tumour effect.
- The findings provide computational evidence supporting the anti-cancer role of bisphosphonates.
Conclusions:
- Bisphosphonates demonstrate a potential anti-tumour effect in multiple myeloma.
- Computational modeling serves as a valuable tool for investigating therapeutic efficacy.
- Further research is warranted to fully elucidate the anti-cancer mechanisms of bisphosphonates in MM.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015